Add to ORKGPatient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI 19 [58%]) of LAI-naïve patients agreed to start LAI treatment following office visits. Patient-described benefits of LAIs Potkin et al. BMC Psychiatry 2013, 13:26
Purpose/Background Medication adherence is a major issue for patients suffering from schizophrenia a...
Martha Sajatovic,1,2 Ruth Ross,3 Susan N Legacy,4 Christoph U Correll,5,6 John M Kane,5,6 Faith DiBi...
INTRODUCTION: Long-acting injectable (LAI) antipsychotics are a useful but underutilized op...
Abstract Background The research goal is to better understand prescriber, patient, and caregiver per...
Background: Long acting injectable antipsychotics (LAI-APs) are considered a major advance in psychi...
Evidence supports the use of long-acting injectable (LAI) antipsychotics in the treatment and preven...
Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for...
Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and would...
Background: Long Acting Injectable (LAI) antipsychotics have been claimed to ensure treatment adher...
cerbated schizophrenia: Conclusions: Patients treated acutely with olanzapine LAI showed a similar p...
is available at the end of the articleBackground Compliance with oral medication is often poor in pa...
Depot antipsychotic drugs, or long-acting injectable antipsychotics (LAIs), have been available sinc...
Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in ...
Long-Acting Injectable Antipsychotics (LAIs) are used to overcome non-compliance in psychoses, mainl...
OBJECTIVE: The authors designed this project to identify barriers to using long-acting formulations ...
Purpose/Background Medication adherence is a major issue for patients suffering from schizophrenia a...
Martha Sajatovic,1,2 Ruth Ross,3 Susan N Legacy,4 Christoph U Correll,5,6 John M Kane,5,6 Faith DiBi...
INTRODUCTION: Long-acting injectable (LAI) antipsychotics are a useful but underutilized op...
Abstract Background The research goal is to better understand prescriber, patient, and caregiver per...
Background: Long acting injectable antipsychotics (LAI-APs) are considered a major advance in psychi...
Evidence supports the use of long-acting injectable (LAI) antipsychotics in the treatment and preven...
Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for...
Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and would...
Background: Long Acting Injectable (LAI) antipsychotics have been claimed to ensure treatment adher...
cerbated schizophrenia: Conclusions: Patients treated acutely with olanzapine LAI showed a similar p...
is available at the end of the articleBackground Compliance with oral medication is often poor in pa...
Depot antipsychotic drugs, or long-acting injectable antipsychotics (LAIs), have been available sinc...
Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in ...
Long-Acting Injectable Antipsychotics (LAIs) are used to overcome non-compliance in psychoses, mainl...
OBJECTIVE: The authors designed this project to identify barriers to using long-acting formulations ...
Purpose/Background Medication adherence is a major issue for patients suffering from schizophrenia a...
Martha Sajatovic,1,2 Ruth Ross,3 Susan N Legacy,4 Christoph U Correll,5,6 John M Kane,5,6 Faith DiBi...
INTRODUCTION: Long-acting injectable (LAI) antipsychotics are a useful but underutilized op...